Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease

Lauren E. Cipriano, Barrett G. Levesque, Gregory S. Zaric, Edward Vincent Loftus, Jr, William J. Sandborn

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: The aim was to examine the cost-effectiveness of magnetic resonance enterography (MRE) compared with computed tomography enterography (CTE) for routine imaging of small bowel Crohn's disease (CD) patients to reduce patients' life-time radiation-induced cancer risk. Methods: We developed a Markov model to compare the lifetime costs, benefits (measured in quality-adjusted life-years [QALYs] of survival and cancers averted) and cost-effectiveness of using MRE rather than CTE for routine disease monitoring in hypothetical cohorts of 100,000 20- year-old patients with CD. We assumed each CT radiation exposure conferred an incremental annual risk of developing cancer using the linear, no-threshold model. Results: In the base case of 16 mSv per CTE, we estimated that radiation from CTE resulted in 1,206 to 20,146 additional cancers depending on the frequency of patient monitoring. Compared to using CTE only, using MRE until age 30 and CTE thereafter resulted in incremental costeffectiveness ratios (ICERs) between $37,538 and $41,031 per life-year (LY) gained and between $52,969 and $57,772 per quality-adjusted lifeyear (QALY) gained. Using MRE until age 50 resulted in ICERs between $58,022 and $62,648 per LY gained and between $84,250 and $90,982 per QALY gained. In a threshold analysis, any use of MRE had an ICER of greater than $100,000 per QALY gained when CT radiation doses are less than 6.0 mSv per CTE exam. Conclusions: MRE is likely cost-effective compared to CTE in patients younger than age 50. Low-dose CTE may be an alternative cost-effective choice in the future.

Original languageEnglish (US)
Pages (from-to)1240-1248
Number of pages9
JournalInflammatory Bowel Diseases
Volume18
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Radiation-Induced Neoplasms
Crohn Disease
Cost-Benefit Analysis
Tomography
Magnetic Resonance Spectroscopy
Quality-Adjusted Life Years
Radiation
Costs and Cost Analysis
Neoplasms
Physiologic Monitoring

Keywords

  • Computed tomography enterography
  • Crohn's disease
  • Inflammatory bowel disease
  • Linear no-threshold model
  • Magnetic resonance enterography
  • Radiation
  • Radiation-induced cancer

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease. / Cipriano, Lauren E.; Levesque, Barrett G.; Zaric, Gregory S.; Loftus, Jr, Edward Vincent; Sandborn, William J.

In: Inflammatory Bowel Diseases, Vol. 18, No. 7, 07.2012, p. 1240-1248.

Research output: Contribution to journalArticle

Cipriano, Lauren E. ; Levesque, Barrett G. ; Zaric, Gregory S. ; Loftus, Jr, Edward Vincent ; Sandborn, William J. / Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease. In: Inflammatory Bowel Diseases. 2012 ; Vol. 18, No. 7. pp. 1240-1248.
@article{61f009cc65f84f8386d9a679533856ac,
title = "Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease",
abstract = "Background: The aim was to examine the cost-effectiveness of magnetic resonance enterography (MRE) compared with computed tomography enterography (CTE) for routine imaging of small bowel Crohn's disease (CD) patients to reduce patients' life-time radiation-induced cancer risk. Methods: We developed a Markov model to compare the lifetime costs, benefits (measured in quality-adjusted life-years [QALYs] of survival and cancers averted) and cost-effectiveness of using MRE rather than CTE for routine disease monitoring in hypothetical cohorts of 100,000 20- year-old patients with CD. We assumed each CT radiation exposure conferred an incremental annual risk of developing cancer using the linear, no-threshold model. Results: In the base case of 16 mSv per CTE, we estimated that radiation from CTE resulted in 1,206 to 20,146 additional cancers depending on the frequency of patient monitoring. Compared to using CTE only, using MRE until age 30 and CTE thereafter resulted in incremental costeffectiveness ratios (ICERs) between $37,538 and $41,031 per life-year (LY) gained and between $52,969 and $57,772 per quality-adjusted lifeyear (QALY) gained. Using MRE until age 50 resulted in ICERs between $58,022 and $62,648 per LY gained and between $84,250 and $90,982 per QALY gained. In a threshold analysis, any use of MRE had an ICER of greater than $100,000 per QALY gained when CT radiation doses are less than 6.0 mSv per CTE exam. Conclusions: MRE is likely cost-effective compared to CTE in patients younger than age 50. Low-dose CTE may be an alternative cost-effective choice in the future.",
keywords = "Computed tomography enterography, Crohn's disease, Inflammatory bowel disease, Linear no-threshold model, Magnetic resonance enterography, Radiation, Radiation-induced cancer",
author = "Cipriano, {Lauren E.} and Levesque, {Barrett G.} and Zaric, {Gregory S.} and {Loftus, Jr}, {Edward Vincent} and Sandborn, {William J.}",
year = "2012",
month = "7",
doi = "10.1002/ibd.21862",
language = "English (US)",
volume = "18",
pages = "1240--1248",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease

AU - Cipriano, Lauren E.

AU - Levesque, Barrett G.

AU - Zaric, Gregory S.

AU - Loftus, Jr, Edward Vincent

AU - Sandborn, William J.

PY - 2012/7

Y1 - 2012/7

N2 - Background: The aim was to examine the cost-effectiveness of magnetic resonance enterography (MRE) compared with computed tomography enterography (CTE) for routine imaging of small bowel Crohn's disease (CD) patients to reduce patients' life-time radiation-induced cancer risk. Methods: We developed a Markov model to compare the lifetime costs, benefits (measured in quality-adjusted life-years [QALYs] of survival and cancers averted) and cost-effectiveness of using MRE rather than CTE for routine disease monitoring in hypothetical cohorts of 100,000 20- year-old patients with CD. We assumed each CT radiation exposure conferred an incremental annual risk of developing cancer using the linear, no-threshold model. Results: In the base case of 16 mSv per CTE, we estimated that radiation from CTE resulted in 1,206 to 20,146 additional cancers depending on the frequency of patient monitoring. Compared to using CTE only, using MRE until age 30 and CTE thereafter resulted in incremental costeffectiveness ratios (ICERs) between $37,538 and $41,031 per life-year (LY) gained and between $52,969 and $57,772 per quality-adjusted lifeyear (QALY) gained. Using MRE until age 50 resulted in ICERs between $58,022 and $62,648 per LY gained and between $84,250 and $90,982 per QALY gained. In a threshold analysis, any use of MRE had an ICER of greater than $100,000 per QALY gained when CT radiation doses are less than 6.0 mSv per CTE exam. Conclusions: MRE is likely cost-effective compared to CTE in patients younger than age 50. Low-dose CTE may be an alternative cost-effective choice in the future.

AB - Background: The aim was to examine the cost-effectiveness of magnetic resonance enterography (MRE) compared with computed tomography enterography (CTE) for routine imaging of small bowel Crohn's disease (CD) patients to reduce patients' life-time radiation-induced cancer risk. Methods: We developed a Markov model to compare the lifetime costs, benefits (measured in quality-adjusted life-years [QALYs] of survival and cancers averted) and cost-effectiveness of using MRE rather than CTE for routine disease monitoring in hypothetical cohorts of 100,000 20- year-old patients with CD. We assumed each CT radiation exposure conferred an incremental annual risk of developing cancer using the linear, no-threshold model. Results: In the base case of 16 mSv per CTE, we estimated that radiation from CTE resulted in 1,206 to 20,146 additional cancers depending on the frequency of patient monitoring. Compared to using CTE only, using MRE until age 30 and CTE thereafter resulted in incremental costeffectiveness ratios (ICERs) between $37,538 and $41,031 per life-year (LY) gained and between $52,969 and $57,772 per quality-adjusted lifeyear (QALY) gained. Using MRE until age 50 resulted in ICERs between $58,022 and $62,648 per LY gained and between $84,250 and $90,982 per QALY gained. In a threshold analysis, any use of MRE had an ICER of greater than $100,000 per QALY gained when CT radiation doses are less than 6.0 mSv per CTE exam. Conclusions: MRE is likely cost-effective compared to CTE in patients younger than age 50. Low-dose CTE may be an alternative cost-effective choice in the future.

KW - Computed tomography enterography

KW - Crohn's disease

KW - Inflammatory bowel disease

KW - Linear no-threshold model

KW - Magnetic resonance enterography

KW - Radiation

KW - Radiation-induced cancer

UR - http://www.scopus.com/inward/record.url?scp=84862168614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862168614&partnerID=8YFLogxK

U2 - 10.1002/ibd.21862

DO - 10.1002/ibd.21862

M3 - Article

C2 - 21928375

AN - SCOPUS:84862168614

VL - 18

SP - 1240

EP - 1248

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 7

ER -